Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)

This study has been completed.
Information provided by (Responsible Party):
Cardium Therapeutics Identifier:
First received: June 28, 2006
Last updated: February 8, 2012
Last verified: November 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)
No publications provided by Cardium Therapeutics

Publications automatically indexed to this study by Identifier (NCT Number):